Bruker Corporation (BRKR)

NASDAQ: BRKR · IEX Real-Time Price · USD
93.94
+0.08 (0.09%)
At close: Mar 28, 2024, 4:00 PM
73.57
-20.37 (-21.68%)
After-hours: Mar 28, 2024, 5:39 PM EDT

Company Description

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.

It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.

In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.

The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bruker Corporation
Bruker logo
Country United States
IPO Date Aug 4, 2000
Industry Medical Devices
Sector Healthcare
Employees 9,707
CEO Dr. Frank H. Laukien Ph.D.

Contact Details

Address:
40 Manning Rd
Billerica, Massachusetts 01821
United States
Phone 978663-3660
Website bruker.com

Stock Details

Ticker Symbol BRKR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001109354
CUSIP Number 116794108
ISIN Number US1167941087
Employer ID 04-3110160
SIC Code 3826

Key Executives

Name Position
Dr. Frank H. Laukien Ph.D. Chairman, Chief Executive Officer and President
Gerald N. Herman Executive Vice President and Chief Financial Officer
Dr. Mark R. Munch Ph.D. Corporate Executive Vice President and President of Bruker Nano Group and Corporate
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Dr. Falko Busse Ph.D. President of Bruker BioSpin Group
Justin Joseph Ward Senior Director of Investor Relations and Corporate Development
J. Brent Alldredge J.D. General Counsel and Secretary
Stacey Desrochers Treasurer and Director of Investor Relations
Dr. Burkhard Prause Ph.D. President and Chief Executive Officer of Bruker Energy and Supercon Technologies, Inc.

Latest SEC Filings

Date Type Title
Mar 4, 2024 144 Filing
Feb 29, 2024 10-K Annual Report
Feb 28, 2024 144 Filing
Feb 22, 2024 144 Filing
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 8-K Current Report
Feb 12, 2024 8-K Current Report
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals